Letrozole-d 4

Overview

Letrozole-d 4 (CGS 20267-d 4 ) is the deuterium labeled Letrozole. Letrozole (CGS 20267) is a potent, selective, reversible and orally active non-steroidal inhibitor of aromatase, with an IC 50 of 11.5 nM. Letrozole selective inhibits estrogen biosynthesis, and can be used for the research of breast cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Autophagy | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Cytochrome P450 | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-14248S
• CAS No.: 1133712-96-5
• Molecular Formula: C17H7D4N5
• Molecular Weight: 289.33
• Purity: 99.23%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source